Racial disparities in age at time of cardiovascular events and cardiovascular-related death in patients with systemic lupus erythematosus
- PMID: 20506536
- PMCID: PMC2946465
- DOI: 10.1002/art.27551
Racial disparities in age at time of cardiovascular events and cardiovascular-related death in patients with systemic lupus erythematosus
Abstract
Objective: To determine whether racial disparities exist with regard to the age at which patients with systemic lupus erythematosus (SLE) experience cardiovascular disease (CVD) and CVD-associated death.
Methods: Using the 2003-2006 Nationwide Inpatient Sample, we calculated the age difference between patients with SLE and their race- and sex-matched controls at the time of hospitalization for a cardiovascular event and for CVD-associated death. In addition, we calculated the age difference between white patients with SLE and sex-matched controls for each minority group for the same outcomes.
Results: The mean age difference between women with and those without SLE at the time of admission for a CVD event was 10.5 years. All age differences between women with SLE (n = 3,627) and women without SLE admitted for CVD were significant (P < 0.0001). Among different racial groups with SLE, black women were the youngest to be admitted with CVD (53.9 years) and to have a CVD-associated in-hospital death (52.8 years; n = 218). Black women with SLE were 19.8 years younger than race- and sex-matched controls at the time of CVD-associated death. Admission trends for CVD were reversed for black women, such that the highest proportions of these patients were admitted before age 55 years, and then the proportions steadily decreased across age categories. Among the 805 men with SLE who were admitted with a CVD event, those who were black or Hispanic were youngest.
Conclusion: There are significant racial disparities with regard to age at the time of hospital admission for CVD events and CVD-related hospitalization resulting in death in patients with SLE.
Figures
Similar articles
-
Towards an understanding of the biopsychosocial determinants of CVD in SLE: a scoping review.Lupus Sci Med. 2024 Jul 24;11(2):e001155. doi: 10.1136/lupus-2024-001155. Lupus Sci Med. 2024. PMID: 39053931 Free PMC article. Review.
-
Age differences in secular trends in black-white disparities in mortality from systemic lupus erythematosus among women in the United States from 1988 to 2017.Lupus. 2021 Apr;30(5):715-724. doi: 10.1177/0961203321988936. Epub 2021 Feb 3. Lupus. 2021. PMID: 33535903
-
Timing and Predictors of Incident Cardiovascular Disease in Systemic Lupus Erythematosus: Risk Occurs Early and Highlights Racial Disparities.J Rheumatol. 2023 Jan;50(1):84-92. doi: 10.3899/jrheum.220279. Epub 2022 Aug 1. J Rheumatol. 2023. PMID: 35914786 Free PMC article.
-
Differences in subclinical cardiovascular disease between African American and Caucasian women with systemic lupus erythematosus.Transl Res. 2009 Feb;153(2):51-9. doi: 10.1016/j.trsl.2008.11.006. Epub 2008 Dec 9. Transl Res. 2009. PMID: 19138649 Free PMC article.
-
Trends and disparities in cardiovascular deaths in systemic lupus erythematosus: A population-based retrospective study in the United States from 1999 to 2020.Curr Probl Cardiol. 2024 Nov;49(11):102801. doi: 10.1016/j.cpcardiol.2024.102801. Epub 2024 Aug 23. Curr Probl Cardiol. 2024. PMID: 39182746 Review.
Cited by
-
Prevalence of cardiovascular events in a population-based registry of patients with systemic lupus erythematosus.Arthritis Res Ther. 2024 Sep 14;26(1):160. doi: 10.1186/s13075-024-03395-6. Arthritis Res Ther. 2024. PMID: 39272198 Free PMC article.
-
Towards an understanding of the biopsychosocial determinants of CVD in SLE: a scoping review.Lupus Sci Med. 2024 Jul 24;11(2):e001155. doi: 10.1136/lupus-2024-001155. Lupus Sci Med. 2024. PMID: 39053931 Free PMC article. Review.
-
Vascular damage in systemic lupus erythematosus.Nat Rev Nephrol. 2024 Apr;20(4):251-265. doi: 10.1038/s41581-023-00797-8. Epub 2024 Jan 3. Nat Rev Nephrol. 2024. PMID: 38172627 Review.
-
Disparities in Lupus and Lupus Nephritis Care and Outcomes Among US Medicaid Beneficiaries.Rheum Dis Clin North Am. 2021 Feb;47(1):41-53. doi: 10.1016/j.rdc.2020.09.004. Epub 2020 Oct 29. Rheum Dis Clin North Am. 2021. PMID: 34042053 Free PMC article. Review.
-
Coronary artery disease (CAD) risk factor analysis in an age-stratified hospital population with systemic lupus erythematosus (SLE).Int J Cardiol Hypertens. 2020 Oct 14;7:100056. doi: 10.1016/j.ijchy.2020.100056. eCollection 2020 Dec. Int J Cardiol Hypertens. 2020. PMID: 33447777 Free PMC article.
References
-
- Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001;44(10):2331–7. - PubMed
-
- Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135–43. - PubMed
-
- HCUP Nationwide Inpatient Sample (NIS) Healthcare Cost and Utilization Project (HCUP) Agency for Healthcare Research and Quality; Rockville, MD:
-
- Hart AC, MSS . ICD-9-CM Expert for Physicians. Salt Lake City, UT: Ingenix; 2006.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
